World Biosimilar Congress USA 2018

By CIOReview | Monday, February 26, 2018

World Biosimilar Congress USA returns to San Diego, CA, May 23-24, 2018 for its third and largest installment yet.

The meeting has become a staple event for biosimilar stakeholders to gather and address the current and future state of Biosimilars in the United States.

This year, with a brand new globally-focused program, the event will be even bigger than before. Among our 100+ speakers are industry leaders from Europe, India, China, Brazil, and several other global markets.

This is the only event to feature 2 dedicated streams for the World Biosimilar Congress (Commercialization & Manufacturing/Development) which will focus on both the business and scientific ends of the biosimilar value chain.

Confirmed speakers from these pioneer brands include: Sandoz, Amgen, Samsung Bioepis, Mylan, UIC, Wockhardt, Polpharma, AstraZeneca, Teva, Cinfa, Sanofi, Medicaid Health Plans of America, Plant Form, Intas, Humana, Kaiser Permanente, and more.

For more information, download the brochure >>

Don’t miss this opportunity to join 300+ of your industry colleagues at the World Biosimilar Congress to find the answers and help shape the future of US healthcare!

Book now to ensure the best price. Register now >>

For sponsorship opportunities, contact:

Fred Sansiveri
Business Development Manager, World Biosimilar Congress USA 2018
Terrapinn
+1 646.619.1838
fred.sansiveri@terrapinn.com